Maeve Waldron-Lynch
- Oncology top 10%
- Cancer Research top 10%
- Pulmonary and Respiratory Medicine top 10%
- Molecular Biology
- Radiology, Nuclear Medicine and Imaging
- Co-authors
- Jennifer Eng‐WongAndreas SchneeweißJavier CortésS KirkTamas HickishAlexandru EniuVernon HarveyStephen Chia
- Topics
- Lung Cancer Treatments and Mutations (13 papers)Lung Cancer Diagnosis and Treatment (9 papers)HER2/EGFR in Cancer Research (5 papers)
- Partner nations
- United StatesGermanySwitzerland
In The Last Decade
Maeve Waldron-Lynch
20 papers receiving 558 citations
Peers
Comparison fields: 5 of 49
- Oncology 427
- Cancer Research 248
- Pulmonary and Respiratory Medicine 228
- Molecular Biology 99
- Radiology, Nuclear Medicine and Imaging 95
Countries citing papers authored by Maeve Waldron-Lynch
This map shows the geographic impact of Maeve Waldron-Lynch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maeve Waldron-Lynch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maeve Waldron-Lynch more than expected).
Fields of papers citing papers by Maeve Waldron-Lynch
This network shows the impact of papers produced by Maeve Waldron-Lynch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maeve Waldron-Lynch. The network helps show where Maeve Waldron-Lynch may publish in the future.
Co-authorship network of co-authors of Maeve Waldron-Lynch
This figure shows the co-authorship network connecting the top 25 collaborators of Maeve Waldron-Lynch. A scholar is included among the top collaborators of Maeve Waldron-Lynch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maeve Waldron-Lynch. Maeve Waldron-Lynch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 1 | |
| 3 | 0 | |
| 4 | Capmatinib in patients with high-level MET-amplified advanced non-small cell lung cancer (NSCLC): results from the phase 2 GEOMETRY mono-1 study | 8 |
| 5 | 8 | |
| 6 | 17 | |
| 7 | 11 | |
| 8 | 2 | |
| 9 | Capmatinib in patients with METex14-mutated or high-level MET-amplified advanced non-small- cell lung cancer (NSCLC) : results from cohort 6 of the phase 2 GEOMETRY mono-1 study | 1 |
| 10 | 4 | |
| 11 | 13 | |
| 12 | 84 | |
| 13 | 27 | |
| 14 | 25 | |
| 15 | 165 | |
| 16 | 144 | |
| 17 | 3 | |
| 18 | 2 | |
| 19 | 36 | |
| 20 | 1 |
About Maeve Waldron-Lynch
Maeve Waldron-Lynch is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine, having authored 21 papers that have together received 564 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (13 papers), Lung Cancer Diagnosis and Treatment (9 papers) and HER2/EGFR in Cancer Research (5 papers). The work is most often cited by research in Cancer Research (248 citations), Oncology (427 citations) and Pulmonary and Respiratory Medicine (228 citations). Maeve Waldron-Lynch has collaborated with scholars based in United States, Germany and Switzerland. Frequent co-authors include Jennifer Eng‐Wong, Andreas Schneeweiß, Javier Cortés, S Kirk, Tamas Hickish, Alexandru Eniu, Vernon Harvey, Stephen Chia, Muhammad Wasif Saif and Sandra M. Swain. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.